Bill Barrett Corporation Announces Results of Purchase Offer for its 5% Convertible Senior Notes Due 2028
DENVER, March 20, 2012 /PRNewswire/ -- Bill Barrett Corporation (the "Company") (NYSE: BBG) announced today the final results of its previously announced offer to purchase its 5% Convertible Senior Notes due 2028 (the "notes") (CUSIP 06846NAA2). The holders' right to tender notes for purchase expired at 9:00 a.m., New York City time, on March 20, 2012 (the "offer").
The Company has been advised by Deutsche Bank Trust Company Americas, the paying agent, that $147,156,000 aggregate principal amount of the notes, representing 85.31% of the total notes currently outstanding, were validly surrendered to the paying agent and not withdrawn. The Company has accepted all such notes for payment. In accordance with the terms of the indenture governing the notes, the Company has forwarded to the paying agent the appropriate amount of cash required to pay the total cash purchase price of approximately $147.3 million for the surrendered notes, including accrued interest, and the paying agent will distribute the cash to the holders as soon as practicable in accordance with the indenture governing the notes. After the offer, $25,344,000 aggregate principal amount of the notes, representing 14.69% of the total notes, is outstanding.
ABOUT BILL BARRETT CORPORATION
Bill Barrett Corporation (NYSE: BBG), headquartered in Denver, Colorado, explores for and develops natural gas and oil in the Rocky Mountain region of the United States. Additional information about the Company may be found on its website www.billbarrettcorp.com.
SOURCE Bill Barrett Corporation
More by this Source
Bill Barrett Corporation Announces Upcoming Investor Events
May 22, 2013, 13:42 ET
Bill Barrett Corporation Schedules Upcoming Investor Events
Apr 25, 2013, 14:43 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.